𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lysis of human chondrosarcoma cells by cytolytic T lymphocytes recognizing a MAGE-A3 antigen presented by HLA-A1 molecules

✍ Scribed by Eric M. Bluman; Pierre G. Coulie; Sun Xiaojuan; Jason Machan; Chouzao Lin; Patricia A. Meitner; Joel A. Block; Richard M. Terek

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
203 KB
Volume
25
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Treatment of chondrosarcomas is limited to resection because these tumors are unresponsive to standard adjuvant treatments, such as chemotherapy and radiation. We have previously shown that high‐grade chondrosarcomas express unspecified members of the Melanoma Antigen (MAGE) gene family. We show here that FS human chondrosarcoma (FS) cells express MAGE‐A3 gene and HLA‐A1 molecules. In vitro assays show that a cytolytic T‐lymphocyte clone (CTL) specific for a MAGE‐A3 peptide presented by HLA‐A1 specifically lysed FS chondrosarcoma cells. Addition of antigenic peptide did not increase the susceptibility of FS cells to CTL mediated lysis, suggesting that HLA‐A1 expression by the chondrosarcoma cells limited their susceptibility to lysis by the anti‐MAGE‐A3 CTL clone. Incubation of FS cells with 50 U/mL interferon‐γ increased surface expression of HLA class‐I molecules, increased their susceptibility to lysis, and had no effect on MAGE‐A3 gene expression. These results suggest that immunotherapy targeted against chondrosarcoma cells is possible. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:678–684, 2007

📜 SIMILAR VOLUMES

A MAGE-A4 peptide presented by HLA-A2 is
A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes
✍ Marie-Thérèse Duffour; Pascal Chaux; Christophe Lurquin; Guy Cornelis; Thierry B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

The MAGE-encoded antigens that are recognized by cytolytic T lymphocytes (CTL) are shared by many tumors and are strictly tumor specific. Clinical trials involving therapeutic vaccination of cancer patients with MAGE antigenic peptides or proteins are in progress. To increase the range of patients e

Two new tumor-specific antigenic peptide
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
✍ Wenbin Ma; Catherine Germeau; Nathalie Vigneron; Anne-Sophie Maernoudt; Sandra M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 236 KB 👁 1 views

## Abstract We have identified 2 antigens recognized by several melanoma‐specific cytolytic T lymphocyte clones isolated from a melanoma patient with a clinical history of tumor regression after immunotherapy. Both antigens are presented by HLA‐A2 and encoded by gene __MAGE‐C2__, a cancer‐germline

Overlapping peptides of melanocyte diffe
Overlapping peptides of melanocyte differentiation antigen melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1
✍ Jörg Schneider; Vincent Brichard; Thierry Boon; Karl-Hermann Meyer zum Büschenfe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB

From the peripheral blood lymphocytes (PBLs) of melanoma patient SK29(AV) we have previously isolated 2 independent cytolytic T lymphocyte (CTL) clones (CTL7/147 and CTL13/211), which lysed autologous tumor cells in association with HLA-B45.1. As demonstrated here, both CTL clones were directed agai

Induction of human leukocyte antigen (HL
Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient
✍ Kanaoka, Shunji; Yamasaki, Seiji; Okino, Takashi; Inoue, Naoya; Shimada, Yutaka; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Background and objectives: Using peripheral blood mononuclear cells (pbmcs) from a 10-year survivor with established human leukocyte antigen (hla)-a2(+) and mage-3(+) esophageal cancer cell line (kyse-170), we examined the induction of hla-a2-restricted and mage-3-gene-derived peptide (flwgpralv

A point mutation in the NFYC gene genera
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma
✍ Mitsuhiro Takenoyama; Jean-Françis Baurain; Manabu Yasuda; Tomoko So; Masakazu S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB

## Abstract We have identified an antigen recognized by cytolytic T lymphocytes (CTL) on the autologous tumor cells of a nonsmall cell lung cancer patient. The antigenic peptide, presented by HLA‐B\*5201 molecules, was encoded by a mutated sequence in the gene coding for the C subunit of transcript